A new study has shown that women are underrepresented in late-breaking cardiovascular clinical trials (LBCT) presented at national meetings. The study is published in the Journal of Women’s Health.
A new study has shown that women are underrepresented in late-breaking cardiovascular clinical trials (LBCT) presented at national meetings. The study is published in the Journal of Women’s Health.
Leave A Comment